Sustained release and activation of the growth factor basic fibroblast growth factor from loaded scaffolds in heart valve tissue engineering

Growth Factors

Volumn 26, Issue 5, 2008, Pages 293-299

  Somers, Pamela ^a   Narine, Kishan ^a   De Somer, Filip ^a   de Vos, Filip ^b   Nooten, Guido V ^a  

^a GHENT UNIVERSITY HOSPITAL   (Belgium)

^b GHENT UNIVERSITY   (Belgium)

Author keywords

BFGF; Biological matrices; Growth factors; Heparin; Tissue engineering

Indexed keywords

BASIC FIBROBLAST GROWTH FACTOR; HEPARIN; IODINE 123;

ANIMAL CELL; ANIMAL TISSUE; AORTA VALVE; ARTICLE; CELL INVASION; CELL PROLIFERATION; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DRUG ACTIVATION; DRUG PROTEIN BINDING; HEART VALVE; IN VITRO STUDY; INCUBATION TIME; ISOTOPE LABELING; NONHUMAN; PRIORITY JOURNAL; SUSTAINED DRUG RELEASE; TISSUE ENGINEERING;

ANIMALS; BIOCOMPATIBLE MATERIALS; BUFFERS; FIBROBLAST GROWTH FACTOR 2; HEART VALVES; HEPARIN; HYDROGEN-ION CONCENTRATION; MATERIALS TESTING; PHOSPHATES; SWINE; TISSUE ENGINEERING; TISSUE SCAFFOLDS;

SUS;

EID: 52649124332     PISSN: 08977194     EISSN: 10292292     Source Type: Journal    
DOI: 10.1080/08977190802303645     Document Type: Article

References (27)

1. Alberts, B., Johnson, A., Lewis, J., Raff, M., Roberts, K. and Walter, P. (2002) Molecular biology of the cell, Garland Science, New York, NY
2. Albes, JM, Klenzner, T., Kotzerke, J., Thiedelmann, KU, Schafers, HJ and Borst, HG (1994) Improvement of tracheal autograft revascularisation by means of fibroblast growth factor. Ann Thorac Surg, 57, pp. 444-449.
3. Balzarotti, M., Fontana, F., Marras, C., Boiardi, A., Croci, D., Ciusani, E. and Salmaggi, A. (2006) In vitro study of low molecular weight heparin effect on cell growth and cell invasion in primary cell cultures of high-grade gliomas. Oncol Res, 16:5, pp. 245-250.
4. Bernfield, M., Gotte, M., Park, PW, Reizes, O., Fitzgerald, ML, Lincecum, J. and Zako, M. (1999) Functions of cell surface heparan sulfate proteoglycans. Annu Rev Biochem, 68, pp. 729-777.
5. Edelman, E., Mathiowitz, E., Langer, R. and Klagsbrun, M. (1991) Controlled and modulated release of basic fibroblast growth factor. Biomaterials, 12, pp. 619-626.
6. Ferrans, VJ, Spray, TL, Billingham, ME and Roberts, WC (1978) Structural changes in glutaraldehyde treated porcine heterografts used as substitute heart valves: Transmission and scanning electron microscopic observations in 17 patients. Am J Cardiol, 41, pp. 1159-1184.
7. Flaumenhaft, R., Moscatelli, D. and Rifkin, DB (1990) Heparin and heparan sulfate increase the radius of diffusion and action of basic fibroblast growth factor. J Cell Biol, 111, pp. 1651-1659.
8. Fujisato, T., Sajiki, T., Liu, Q. and Ikada, Y. (1996) Effect of basic fibroblast growth factor on cartilage regeneration in chondrocyte-seeded collagen sponge scaffold. Biomaterials, 17:2, pp. 155-162.
9. Gallagher, JT (2001) Heparan sulfate: Growth control with a restricted sequence menu. J Clin Invest, 108, pp. 357-361.
10. Gospodarowicz, D. and Cheng, J. (1986) Heparin protects basic and acidic FGF from inactivation. J Cell Physiol, 128:3, pp. 475-484.
11. Hammermeister, K., Sethi, GK and Henderson, WG (2000) Outcomes 15 years after valve replacement with a mechanical versus a bioprosthetic valve: Final report of the veterans affairs randomised trial. J Am Coll Cardiol, 36:4, pp. 1152-1158.
12. Lai, PH, Chang, Y., Chen, SC, Wang, CC, Liang, HC, Chang, WC and Sung, HW (2006) Acellular biological tissues containing inherent GAGs for loading basic fibroblast growth factor promote angiogenesis and tissue regeneration. Tissue Eng, 12:9, pp. 2499-2508.
13. Lane, DA and Lindahl, U. (1989) Highlights in the history of heparin. In heparin: Chemical and biological properties, clinical applications, pp. 1-23. CRC Press, Boca Raton, FL
14. Lin, X. (2004) Functions of heparan sulphate proteoglycans in cell signalling during development. Development, 131:24, pp. 6009-6021.
15. Mareel, MM, Bracke, ME, Van Roy, FM and De Baetselier, P. (1997) Molecular mechanisms of cancer invasion. Encyclopedia of cancer, pp. 1072-1083. Academic Press, San Diego, CA
16. Marks, MG, Doillon, C. and Silver, FH (1991) Effects of fibroblast and basic fibroblast growth factor on dermal wound healing by type I collagen matrices. J Biomed Mat Res, 25, pp. 683-696.
17. Narine, K., Claeys, E., Cornelissen, M., De Somer, F., Beele, H., Vanlangenhove, L., De Smet, S. and Van Nooten, G. (2006) Readily available porcine aortic matrices for use in tissue valve engineering. Is cryopreservation an option?. Cryobiology, 53:2, pp. 169-181.
18. Narine, K., Dewever, O., Van Valckenborgh, D., Francois, K., Bracke, M., De Smet, S., Mareel, M. and Van Nooten, G. (2006) Growth factor modulation of fibroblast proliferation, differentiation, and invasion: Implications for tissue valve engineering. Tissue Eng, 12:10, pp. 2707-2716.
19. Perets, A., Baruch, Y., Weisbuch, G., Shoshany, G., Neufeld, G. and Cohen, S. (2003) Enhancing the vascularization of three-dimensional porous alginate scaffolds by incorporating controlled release of basic fibroblast growth factor microspheres. J Biomed Mater Res, 65, pp. 489-497.
20. Steffens, GCM, Yao, C., Prevel, P., Markowicz, M., Schenck, P., Noah, EM and Pallua, N. (2004) Modulation of angiogenic potential of collagen matrices by covalent incorporation of heparin and loading with vascular endothelial growth factor. Tissue Eng, 10, pp. 1502-1509.
21. Sweeney, SM, Guy, CA, Fields, GB and San Antonio, JD (1998) Defining the domains of type I collagen involved in heparin-binding and endothelial tube formation. Proc Natl Acad Sci, 95:13, pp. 7275-7280.
22. Tae, G., Scatena, M., Stayton, PS and Hoffman, AS (2006) PEG-cross-linked heparin is an affinity hydrogel for sustained release of vascular endothelial growth factor. J Biomater Sci Polym Ed, 17:1, pp. 187-197.
23. Taipale, J. and Keski-Oja, J. (1997) Growth factors in the extracellular matrix. FASEB J, 11, pp. 51-59.
24. Wang, XH, Li, DP, Wang, WJ, Feng, QL, Cui, FZ, Xu, YX and Song, XH (2003) Covalent immobilization of chitosan and heparin on PLGA surface. Int J Biol Macromol, 33, pp. 95-100.
25. Wilson, GJ, Courtman, DW, Klement Peter, Lee, JM and Yeger, H. (1995) Acellular matrix: A biomaterials approach for coronary artery bypass and heart valve replacement. Ann Thorac Surg, 60, pp. 353-358.
26. Yayon, A., Klagsbrun, M., Esko, J., Leder, P. and Ornitz, D. (1991) Cell surface, heparin-like molecules are required for binding of basic fibroblast growth factor to its high affinity receptor. Cell, 64, pp. 841-848.
27. Zeltinger, J., Landeen, LK, Alexander, HG, Kidd, IG and Sibanda, B. (2001) Development and characterisation of tissue-engineered aortic valves. Tissue Eng, 7:1, pp. 9-22.